GlassScriptPhysician profile
Audrey Franks
NPI 1689093239
$1,967.54
in general payments reported to CMS, 2019-2025
16 companies · $67.47 in 2025
The $67.47 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $107 · 2022: $605 · 2023: $574 · 2024: $614 · 2025: $67.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,256.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $363.74 | 2022-2024 | Mounjaro, Jardiance, Zepbound |
| Exact Sciences Corporation | $276.32 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $219.10 | 2021-2024 | Repatha, Otezla |
| Abbvie INC. | $213.73 | 2022-2024 | |
| Novo Nordisk INC | $198.85 | 2021-2023 | Ozempic, Rybelsus |
| Boston Scientific Corporation | $178.25 | 2024 | Watchman Flx |
| Bayer Healthcare Pharmaceuticals INC. | $141.60 | 2022 | |
| Pfizer INC. | $90.58 | 2022-2024 | |
| Glaxosmithkline, LLC. | $56.47 | 2022-2023 | Trelegy Ellipta |
| Grt US Holding, INC. | $54.67 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $53.71 | 2024 | Gemtesa |
| Novartis Pharmaceuticals Corporation | $31.74 | 2022 | |
| Astellas Pharma US INC | $31.68 | 2024 | Veozah |
| Astrazeneca Pharmaceuticals LP | $30.18 | 2024 | Airsupra |
| Idorsia Pharmaceuticals US INC | $14.63 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $12.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Franks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.